DiseaseID 4060
胃泌素瘤
disease
NCI2016_NCI-GLOSS_1602D:A tumor that causes overproduction of gastric acid. It usually begins in the duodenum (first part of the small intestine that connects to the stomach) or the islet cells of the pancreas. Rarely, i
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Disease: 1Symptom: 7Target: 12Links: 19
Arranging relationship network...
Record Fields
Scalar fields from the final disease record.
- Disease Id
- 4060
- Core Entity Id
- 60348
- Source Entity Count
- 1
- Preferred Name
- Gastrinoma
- Name Cn
- 胃泌素瘤
- Name Pinyin
- Wei Mi Su Liu
- Name En
- Gastrinoma
- Name Latin
- Bilingual Status
- complete
- Disease Type
- disease
- Umls Disease Type
- Neoplastic Process
- Disgenet Type
- disease
- Mesh Class
- Digestive System Diseases; Neoplasms; Endocrine System Diseases
- Do Class
- disease of anatomical entity; disease of cellular proliferation
- Hpo Class
- Mesh Class Name
- Digestive System Diseases; Neoplasms; Endocrine System Diseases
- Hpo Class Name
- Do Class Name
- disease of anatomical entity; disease of cellular proliferation
- Disease Definition
- NCI2016_NCI-GLOSS_1602D:A tumor that causes overproduction of gastric acid. It usually begins in the duodenum (first part of the small intestine that connects to the stomach) or the islet cells of the pancreas. Rarely, it may also begin in other organs, including the stomach, liver, jejunum (the middle part of the small intestine), biliary tract (organs and ducts that make and store bile), mesentery, or heart. It is a type of neuroendocrine tumor, and it may metastasize (spread) to the liver and the lymph nodes.|NCI2016_02D:A gastrin-producing neuroendocrine tumor. It is usually located in the pancreas but it is also found at other anatomic sites, including the stomach and small intestine.|MSH2017_2016_08_12:A GASTRIN-secreting neuroendocrine tumor of the non-beta ISLET CELLS, the GASTRIN-SECRETING CELLS. This type of tumor is primarily located in the PANCREAS or the DUODENUM. Majority of gastrinomas are malignant. They metastasize to the LIVER; LYMPH NODES; and BONE but rarely elsewhere. The presence of gastrinoma is one of three requirements to be met for identification of ZOLLINGER-ELLISON SYNDROME, which sometimes occurs in families with MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; (MEN 1).
- Version
- v2
- Suppressed
- No
Names
Preferred names, aliases, and source labels retained in the final schema.
Name
Gastrinoma
Role
preferred
Cross References
Trusted external identifiers retained for this final record.
Herb
HBDIS001132
Me Sh
D015408
Umls
C0017150
Sym Map
SMDE08944
Do Class
DOID:14566DOID:7
Dis Ge Net
C0017150
Umls Sty
T191
Me Sh Class
C04C06C19
Tcmbank Disease
31812
Attributes
Merged source attributes and domain-specific metadata.
Version
v2
Suppress
0
Do Class Name
disease of anatomical entity; disease of cellular proliferation
Disease Type
disease
Do Disease Class
disease of anatomical entity; disease of cellular proliferation
Umls Disease Type
Neoplastic Process
Disease Definition
NCI2016_NCI-GLOSS_1602D:A tumor that causes overproduction of gastric acid. It usually begins in the duodenum (first part of the small intestine that connects to the stomach) or the islet cells of the pancreas. Rarely, it may also begin in other organs, including the stomach, liver, jejunum (the middle part of the small intestine), biliary tract (organs and ducts that make and store bile), mesentery, or heart. It is a type of neuroendocrine tumor, and it may metastasize (spread) to the liver and the lymph nodes.|NCI2016_02D:A gastrin-producing neuroendocrine tumor. It is usually located in the pancreas but it is also found at other anatomic sites, including the stomach and small intestine.|MSH2017_2016_08_12:A GASTRIN-secreting neuroendocrine tumor of the non-beta ISLET CELLS, the GASTRIN-SECRETING CELLS. This type of tumor is primarily located in the PANCREAS or the DUODENUM. Majority of gastrinomas are malignant. They metastasize to the LIVER; LYMPH NODES; and BONE but rarely elsewhere. The presence of gastrinoma is one of three requirements to be met for identification of ZOLLINGER-ELLISON SYNDROME, which sometimes occurs in families with MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; (MEN 1).
Me Sh Disease Class
Digestive System Diseases; Neoplasms; Endocrine System Diseases
Dis Ge Net Disease Type
disease
Disease Class Name Me Sh
Digestive System Diseases; Neoplasms; Endocrine System Diseases
Umls Semantic Type Name
Neoplastic Process